Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Management of severe dengue hemorrhagic fever and bleeding complications in a primigravida patient: a case report

  • Hori Hariyanto1Email author,
  • Corry Quando Yahya2,
  • Primartanto Wibowo1 and
  • Oloan E. Tampubolon1
Journal of Medical Case Reports201610:357

https://doi.org/10.1186/s13256-016-1129-7

Received: 3 October 2016

Accepted: 1 November 2016

Published: 20 December 2016

Abstract

Background

The incidence of dengue hemorrhagic fever is increasing among the adult population living in endemic areas. The disease carries a 0.73% fatality rate for the general population, but what happens when the disease strikes a special subpopulation group, the obstetrics? Perhaps the important question specific to this special subpopulation revolves around the right time and mode of delivery under severe coagulopathy and plasma leakage in conditions of imminent delivery.

Case presentation

A 24-year-old primigravid Sundanese woman presented to our intensive care unit due to acute pulmonary edema secondary to massive plasma leakage caused by severe dengue. She tested positive for both immunoglobulin G and immunoglobulin M dengue serology indicating she had secondary dengue infection, which placed her at risk for an exaggerated cytokine response as was evident clinically. She had to undergo an emergency cesarean section which was later complicated by rebleeding and hemodynamic instability due to an atypical defervescence period. She was successfully managed by multiple blood transfusions and was discharged from our intensive care unit on day 8 without any negative sequel.

Conclusions

Fever, thrombocytopenia, and hemoconcentration are the classical symptoms of dengue hemorrhagic fever observed in adult, pediatric, and obstetric populations. However, a clinician must be particularly watchful in treating a pregnant dengue-infected patient as physiologic hematology changes provide greater volume compensation and the advent of shock marks significant volume loss. In conclusion, an important principle in the management of dengue hemorrhagic fever in pregnancy is to prioritize maternal well-being prior to addressing fetal issues.

Keywords

Dengue hemorrhagic fever Bleeding Pregnancy Transfusions Case report

Background

Dengue is a common tropical infectious disease with a rising incidence among the Indonesian population. In 2013, its annual incidence was reported to be 35 to 40/100,000 with a mean age of above 15-years old and a case fatality rate of 0.73% [1]. The classical form of dengue infection is manifested as high fever, violent headaches, thrombocytopenia, and hemoconcentration. Such presentations are similar to those within the obstetric population; however, bleeding tendency is increased especially for both the mother and the neonate due to hemostatic defects which might lead to uncontrolled bleeding [2].

The management of dengue hemorrhagic fever during pregnancy warrants careful monitoring as physiologic hemodilution may mask hemoconcentration leading to late diagnosis and late management of the severely volume-depleted patient. Plasma leakage accumulates along the tissue interstitial space and causes inadequate tissue oxygenation. Prolonged disturbance may develop into multiorgan failure and rapid fetal demise especially in the obstetric population where oxygen consumption is twice as high as the healthy adult [3].

Fluid therapy and identification of the critical phase are the most important aspects of management, but what does clinical evidence say about dengue infection in the obstetric population? Diagnosis of dengue infection during pregnancy surely affects management options and decisions as the mode and time of delivery are of utmost importance. In this case report, we will discuss the pathophysiology and management of severe dengue hemorrhagic fever and bleeding complications in an intensive care unit (ICU).

Case presentation

A 24-year-old Sundanese primigravid woman was referred from a peripheral hospital at 38 weeks of gestation due to her deteriorating condition. She presented initially for 5 days of high grade fever, retro-orbital pain, and a blood examination which revealed thrombocytopenia, elevated liver enzymes, and a positive immunoglobulin M (IgM) and immunoglobulin G (IgG) dengue serology. She was diagnosed as having dengue fever in pregnancy and treated with fluid administered intravenously and antipyretics. However, her condition started to worsen on day five of hospitalization with repeated bouts of vomiting and she became lethargic. Her weight was 45 kg and her antenatal history did not reveal hypertension, pre-eclampsia, coagulation abnormalities, or epilepsy.

During her transport, she received 10 liters of oxygen by non-rebreathing mask and had experienced two episodes of generalized tonic–clonic seizure, each lasting less than 1 minute which terminated with 10 mg diazepam administered intravenously. On admission to our ICU, she was responsive only to pain with a blood pressure of 92/76 mmHg, heart rate 124/minute, respiratory rate 30/minute, body temperature 36.6 °C, and oxygen saturation of 95%. A physical examination revealed diffuse rales on both lungs with cold and clammy extremities. Her chest X-ray revealed marked bronchovascular marking on her left and right basal lung regions (Fig. 1). Arterial blood gas analysis revealed an acute metabolic alkalosis: pH 7.510, partial pressure of oxygen in arterial blood (PaO2) 166 mmHg, partial pressure of carbon dioxide in arterial blood (PaCO2) 41.3 mmHg, bicarbonate (HCO3-) 33.0 mmol/L, and base excess (BE) 9.3 mmol/L. An initial diagnosis of dengue encephalitis, and dengue shock syndrome with acute pulmonary edema was made.
Fig. 1

Chest X-ray upon initial admission

She was immediately intubated and placed on mechanical ventilation using adaptive support ventilation mode with the following settings: minute ventilation of 4.5 L, positive end-expiratory pressure (PEEP) 5 cmH2O, and fraction of inspired oxygen (FiO2) of 50% and received continuous sedation under morphine and midazolam infusion. During anesthesia induction, her blood pressure dropped to 60/40 mmHg and a fluid bolus of 300 mL normal saline was given to which she responded. Arterial blood gas analyses taken 2 hours post-intubation with a FiO2 0.7 were as follows: pH 7.475, PaO2 159.1 mmHg, PaCO2 32.1 mmHg, HCO3- 24.2 mmol/L and BE 1.1 mmol/L. Another important event included traumatic gum bleeding from biting during her seizure episode which took 1 hour to attain hemostasis, and insertion of a nasogastric tube which yielded 100 mL of dark brown fluid.

On day 1, hematologic results revealed hemoglobin (Hgb) of 11.7 g/dL (normal range, N, 11.70 to 15.50 g/dL), hematocrit (Hct) of 36.80% (N, 35.00 to 47.00), and white cell count (WBC) of 10,430/mm3 (N, 3600 to 11,000/ mm3) with 53% neutrophil predominance and 35% lymphocytes. Her platelet (Plt) count was 25,000/uL (N, 150,000 to 440,000), prothrombin time (PT) 10.40 seconds (N, 9.4 to 11.3) with an international normalized ratio (INR) of 1.00, activated partial thromboplastin time (aPTT) of 48.70 (N, 31 to 45 seconds), and a slightly elevated D-dimer of 1.91 ng/mL (N, 0.00 to 0.30). Her bilirubin levels were normal, she had an alanine aminotransferase (ALT) level of 116 U/L (N, 0 to 55), aspartate transaminase (AST) of 359 U/L (N, 5 to 34), urea of 49.0 mg/dL (N, <50), creatinine of 0.85 mg/dL (N, 0.5 to 1.1), lactic acid of 4.7 mmol/L (N, <0.6 to 2.2) and procalcitonin of 0.25 ng/mL (N, <0.15). Her urine was tinted red and complete analysis revealed the presence of slight proteinuria (100 mg/dL) and occult blood (200 cells/uL). Cardiotocography (CTG) monitoring revealed a fetal heart rate of 177 beats per minute (bpm) with no uterine contractions.

On day 2, a routine CTG monitoring revealed fetal distress which prompted an emergency cesarean section. She received 500 mL fresh frozen plasma (FFP) before being rushed for cesarean section under general anesthesia. Intraoperative bleeding was 500 mL, an intra-abdominal drain was placed and she received 460 mL of packed red cell (PRC), intraoperatively. A 2.1 kg baby girl was delivered with an appearance, pulse, grimace, activity and respiration (APGAR) score of 4/7. The baby was intubated and transferred to our neonatal ICU (NICU) due to hypoventilation. Our patient was transferred back to ICU and fundal height was noted at the level of umbilicus with good contractions.

On day 3, blood clots were seen oozing from her vagina and a vaginal exploration evacuated 200 mL of blood. The intra-abdominal drain collected 50 mL/24 hours of hemoserous fluid and hematologic results revealed Hgb 5.9 g/dL, Hct 18.20%, and Plt 141,000/uL. Upon this substantial drop, 680 mL of PRC, 210 mL of FFP, and 2 units of thrombocyte concentrate apheresis (TCA) were given. Her vital parameters were stable and she remained sedated. A follow-up chest radiography revealed improved clearance of vascular markings on both lung fields confirmed by vesicular lung sounds and a normal acid-base balance with a PaO2/FiO2 of 600 (Fig. 2).
Fig. 2

Chest X-ray on day 3 of hospitalization

On day 4, a follow up hematologic examination revealed Hgb 6.96 g/dL, Hct 20.16%, WBC 10,660/mm3, Plt 98,630/uL, albumin 2.63 g/dL, fibrinogen 140 mg/dL (N, 300 to 600), PT 10.90 seconds, and a prolonged aPTT of 56.90 seconds. The intra-abdominal drain collected 450 mL/24 hours of hemoserous fluid and her lower abdomen was noted to be slightly distended. Thereafter, another 230 mL of PRC, 240 mL of FFP, and 2 units of thrombocyte concentrate (TC) was transfused.

On day 5, 3 days post-cesarean section, our patient became tachycardic with a blood pressure of 80/60 mmHg, which prompted the use of norepinephrine at 0.08 μg/kg/minute. Uterine contractions were adequate with normal colored lochia, but her lower abdomen appeared distended as before. The intra-abdominal drain collected 360 mL/24 hours of hemoserous fluid and laboratory results were as follow: Hgb 5.90 g/dL, Hct 17.80%, WBC14,020/mm3, Plt 107,000/uL, and albumin of 2.26 g/dL. She was given 20% albumin infusion, 230 mL of PRC, and 220 mL of FFP.

On day 6, she remained tachycardic and her mentation did not improve despite stopping sedation. At this time, her lower abdomen appeared more distended and abdominal guarding was noted upon palpation. The intra-abdominal drain had collected 850 mL/24 hours of hemoserous fluid. An urgent blood workup revealed a drop in Hgb to 4.20 g/dL, Hct 12.50%, WBC 10,160/mm3, Plt 84,000/uL, PT 10.40 seconds, aPTT 49.50 seconds, and a spiked D-dimer level (20.25 ug/mL). An emergent ultrasound revealed free fluid on her lower abdominal region which required her to be rushed for an exploratory laparotomy. The procedure evacuated 2000 mL of blood intra-abdominally, and she received 640 mL of PRC and 500 mL FFP, intraoperatively.

On day 7, her hematologic examination revealed Hgb 9.60 g/dL, Hct 28.50%, WBC 8,150/mm3, Plt 67,000/uL, normalized coagulation profile, and a lowered D-dimer level (13.98 ug/mL). One unit of TC was transfused and norepinephrine infusion was tapered down with strict vital sign monitoring. Sedation was stopped and her mentation greatly improved. A follow-up chest radiograph revealed clear lung fields and she was placed on a spontaneous breathing trial which was successful and she was later extubated.

On day 8, an additional 230 mL PRC was given and her hematologic examination revealed Hgb 11.50 g/dL, Hct 34.40%, and Plt 83,000/uL. Aside from transfusions and vasopressors, she received meropenem 1 gram every 8 hours, early enteral nutrition of 1000 kcal/24 hours, gastric acid prophylaxis agent, gastric motility agents, and anticonvulsants. She was transferred to our general ward on day 8 and discharged from our hospital on day 11, uneventfully. Her neonate was extubated on day 2 of her NICU stay, after complete recovery from sedative drugs in utero and discharged home at day 5 without any negative sequel (Table 1).
Table 1

Daily hematology trend and therapy

  

Day 1

Day 2

Day 3

Day 4

Day 5

Day 6

Day 7

Day 8

Therapy given prior to blood test results

Packed red cell (mL)

None

460

None

None

None

None

None

230

Thrombocyte concentrate apheresis (Unit)

None

None

None

None

None

None

None

None

Fresh frozen plasma (mL)

None

500

None

None

None

None

None

None

Hemogram

Hemoglobin (g/dL)

11.7

13.3

5.9

6.96

5.9

4.2

9.6

11.5

Hematocrit (%)

36.8

41.9

18.2

20.16

17.8

12.5

28.5

34.4

White blood cell (/mm3)

10,430

10,690

11,390

10,660

14,020

10,160

8150

 

Platelets (/μL)

25,000

31,000

141,000

98,030

107,000

84,000

67,000

83,000

Coagulation studies

Prothrombin time (seconds)

10.4

10.9

12.1

10.9

10.4

10.4

9.9

10.2

Activated partial thromboplastin time (seconds)

48.7

46.1

51.7

56.9

55.2

49.5

45.6

41.5

D-dimer (μg/mL)

1.91

2.71

1.49

5.36

18.96

20.25

13.98

11.2

Fibrinogen (mg/dL)

N/A

N/A

N/A

140

N/A

N/A

N/A

N/A

Therapy given after blood results

Packed red cell (mL)

None

None

680

230

230

640

None

None

Thrombocyte concentrate apheresis (Unit)

None

None

2

2

None

None

1

None

Fresh frozen plasma (mL)

None

None

210

240

220

500

None

None

Amount of blood collected + abdominal drain (mL/24 hours)

  

500 (cesarean section)

50

450

360

850 + 2000 evacuated intra-abdomen

Minimal

Minimal

N/A not available

Discussion

Dengue infection presents with a febrile period of 2 to 7 days followed by 3 to 4 days of defervescence phase marked by massive plasma leakage which may progress to shock [4]. Recall that during pregnancy, the body experiences physiologic changes with respect to the cardiovascular, respiratory, and hematologic systems [5]. At the end of the third trimester, plasma volume increases by approximately 40% resulting in dilutional anemia which masks the ‘hemoconcentration’ commonly observed during the defervescence phase of dengue hemorrhagic fever. The finding is confirmed as our patient was at her tenth day of illness. She was at the ‘critical’ phase of dengue infection with a normal Hct; nevertheless, she was in a state of shock with altered mental status and reduced perfusion.

Severe manifestations of dengue infection are reported to be a combination of factors from the host, viral virulence, and those presenting with secondary exposures [6]. The dengue virus replicates intracellularly and carries tropism to endothelial cells, pulmonary cells, and gastrointestinal cells which triggers an antigen-antibody complex causing immune-mediated cell destruction and the production of cytokines and antibodies [7]. Our patient tested positive on IgG and IgM serology test, thus categorizing her with secondary dengue infection, which increases the risk for an exaggerated cytokine cascade response; this response was made clinically evident by severe thrombocytopenia (<50,000), elevated liver enzymes, mucosal bleeding, and massive plasma leakage which contributed to the development of acute pulmonary edema [8].

On arrival to our ICU, our patient was only responsive to pain stimulation with significant tachypnea and labored breathing. In pregnancy, the normal arterial pH is 7.45 with a PaCO2 of 30 mmHg due to increased minute ventilation. Our patient revealed alkalosis with a rising paCO2 level of 41.3 mmHg indicating that she was developing fatigue marked by CO2 retention and impaired ventilation [5]. Marked vascular markings on radiologic examination and crackles upon lung auscultation signify a potential disruption in the process of oxygenation. More importantly, the obstetric patient requires a greater amount of oxygen to meet her basal metabolic rate and every pregnant patient is considered at risk for aspiration due to reduced gastric emptying time [5]. For these reasons, she was intubated and supported by mechanical ventilation.

Perhaps the most important question to ask revolves around the mode and timing of delivery of a severely thrombocytopenic patient. Should delivery be performed even before the onset of fetal distress and what are the recommended guidelines on thrombocytopenia in pregnancy? Two units of FFP were transfused as recommended by World Health Organization transfusion guidelines prior to elective surgical procedures [9, 10]. We believe cesarean section performed on our patient due to fetal distress was the appropriate decision. On her arrival to our institution, optimization of maternal status was aggressively pursued in order to provide optimal oxygen delivery to the fetus. Unfortunately, the fetus’s condition deteriorated which may have been a result of prior maternal hypoxemia and alkalotic condition disrupting oxygen release to tissue. General anesthesia was the preferred mode of delivery as neuraxial anesthesia was impossible owing to our patient’s respiratory distress and thrombocytopenia [11]. After the operation, she was given 2 units of PRC and an intra-abdominal drain was inserted in anticipation of bleeding diathesis.

Over the next few days, insidious bleeding occurred as her Hgb substantially plummeted from 13.3 g/dL to 4.2 g/dL within 4 days. Even though thrombocytopenia is universally observed in dengue hemorrhagic fever, it is a poor indicator of bleeding manifestation. It is rather the low fibrinogen levels and prolonged aPTT which are the main culprits for coagulopathy [12]. Normal pregnancy is a state of hypercoagulopathy due to a physiologic increase in coagulation factors [13]. By contrast, our patient had lowered fibrinogen levels and prolonged aPTT. This is caused by increased vascular permeability causing leakage of fibrinogen into the interstitial spaces while pronounced cytokine response causes damage to glycocalyx along the endothelial linings and liberates heparin sulfate into the circulation, thereby disrupting the intrinsic coagulation pathway [14]. Such disturbance combined with a recent operative procedure triggered the ongoing hemorrhage in our patient.

The critical phase of dengue hemorrhagic fever lasts 2 to 4 days, but our patient continued to face hemostatic defects and volume depletion up to her sixth day. During her secondary infection of dengue, the binding of the new virus to cross-reactive antibodies from her previous infection resulted in the uptake of virus into mononuclear phagocytes. This enables the virus to amplify viral replication resulting in a higher viral antigen load and an exaggerated form of coagulopathies and vascular permeability [7, 15]. The plasma leakage is caused by the functional disruption of adherens junction, a network of adhesion proteins in the intracellular cytoskeleton that retract and create gaps between cells promoting leakage of plasma and coagulation proteins, which is transient and resolves itself as the cytokine response wears off [6].

Throughout the course of her ICU stay, our patient received a total of 11 units of PRCs, 7 units of FFP, 2 units of TCA, and 3 units of TC. Apart from blood product transfusions, treatment of severe dengue hemorrhagic fever includes judicious fluid therapy during the ‘critical’ phase to avoid leakage of fluids into the fragile pulmonary capillaries. Hence, we used 20 ml/hour of normal saline infusion while striving for zero fluid balance and maintaining a diuretic goal of 1 mL/kg/hour. Stable vital signs, clearance of vascular markings on the chest X-ray, and a normalized PaO2/FiO2 ratio indicated appropriate fluid titration in our patient.

Conclusions

Current evidence has reported similarities in symptoms and laboratory findings in the obstetric population infected by dengue hemorrhagic fever. However, clinicians must be aware that secondary dengue infections may manifest an atypical period of defervescence phase marked by severe prolonged coagulopathies and plasma leakage. Hence, the management of dengue-infected obstetric patients is aimed at conservative fluid therapy and transfusion of blood product when signs of bleeding occur. An important principle to remember is to prioritize maternal well-being prior to addressing fetal issues. Next, a delivery plan via the fastest route and timely administration of blood products prior to delivery is essential in order to deliver the most beneficial outcome for both the mother and fetus.

Declarations

Acknowledgements

Not applicable.

Funding

None received.

Availability of data and materials

Please contact author for data requests.

Authors’ contributions

HH, PW, and OT contributed to making a diagnosis and treatment strategy for this patient. CY and HH conceived writing this report and coordinated to draft the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Ethics approval and consent to participate

Not applicable.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Anesthesiology and Critical Care Medicine
(2)
Department of Anesthesiology, Universitas Pelita Harapan Faculty of Medicine

References

  1. Karyanti MR, Uiterwaal CSPM, Kusriastuti R, Hadinegoro SR, Rovers MM, Heesterbeek H, et al. The changing incidence of Dengue Haemorrhagic Fever in Indonesia: a 45-year registry-based analysis. BMC Infect Dis. 2014;14(1):1–7.View ArticleGoogle Scholar
  2. Chitra TV, Panicker S. Maternal and fetal outcome of dengue fever in pregnancy. J Vector Borne Dis. 2011;48(4):210–3.PubMedGoogle Scholar
  3. Trikha A, Singh PM. The critically ill obstetric patient – Recent concepts. Indian J Anaesth. 2010;54(5):421–7.View ArticlePubMedPubMed CentralGoogle Scholar
  4. World Health Organization. Handbook of clinical management of dengue. Geneva: World Health Organization; 2012. p. 124.Google Scholar
  5. Costantine MM. Physiologic and pharmacokinetic changes in pregnancy. Front Pharmacol. 2014;5:65.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Martina BEE, Koraka P, Osterhaus ADME. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 2009;22(4):564–81.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Sellahewa KH. Pathogenesis of dengue haemorrhagic fever and its impact on case management. ISRN Infect Dis. 2013;2013:6.Google Scholar
  8. Nachman RL, Rafii S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med. 2008;359(12):1261–70.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3):205–13.View ArticlePubMedGoogle Scholar
  10. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med. 2012;157(1):49–58.View ArticlePubMedGoogle Scholar
  11. Rollins M, Lucero J. Overview of anesthetic considerations for Cesarean delivery. Br Med Bull. 2012;101(1):105–25.View ArticlePubMedGoogle Scholar
  12. Wills B, Tran VN, Nguyen TH, Truong TT, Tran TN, Nguyen MD, et al. Hemostatic changes in Vietnamese children with mild dengue correlate with the severity of vascular leakage rather than bleeding. Am J Trop Med Hyg. 2009;81(4):638–44.View ArticlePubMedGoogle Scholar
  13. Szecsi PB, Jørgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S. Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010;103(4):718–27.View ArticlePubMedGoogle Scholar
  14. Palmer RN, Rick ME, Rick PD, Zeller JA, Gralnick HR. Circulating Heparan Sulfate Anticoagulant in a Patient with a Fatal Bleeding Disorder. N Engl J Med. 1984;310(26):1696–9.View ArticlePubMedGoogle Scholar
  15. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis. 2006;193(8):1078–88.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement